Literature DB >> 18389471

Isolation of linoleic and alpha-linolenic acids as COX-1 and -2 inhibitors in rose hip.

A K Jäger1, K N Petersen, G Thomasen, S Brøgger Christensen.   

Abstract

Rose hip has previously shown clinical efficacy in the treatment of osteoarthritis, and organic solvent extracts of rose hip have showed inhibition of cyclooxygenase-1 and -2. A petroleum ether extract of rose hip was fractioned by VLC on silica; on a C-18 column and by HPLC. Each step was COX-1/2 activity-guided. The bioassay-guided fractionation led to the isolation of linoleic acid (the IC50 for COX-1 was 85 microm and 0.6 microM for COX-2) and alpha-linolenic acid (the IC50 for COX-1 was 52 microM and 12 microM for COX-2). The COX-2/COX-1 ratio was 0.007 for linoleic acid and 0.2 for alpha-linolenic acid. Linoleic acid and alpha-linolenic acid contribute to the COX-1 and -2 inhibitory activity of rose hip.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389471     DOI: 10.1002/ptr.2446

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  10 in total

Review 1.  Oral herbal therapies for treating osteoarthritis.

Authors:  Melainie Cameron; Sigrun Chrubasik
Journal:  Cochrane Database Syst Rev       Date:  2014-05-22

2.  Rosehip inhibits xanthine oxidase activity and reduces serum urate levels in a mouse model of hyperuricemia.

Authors:  Hidetomo Kikuchi; Satomi Kogure; Rie Arai; Kouki Saino; Atsuko Ohkubo; Tadashi Tsuda; Katsuyoshi Sunaga
Journal:  Biomed Rep       Date:  2017-04-10

Review 3.  Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacology.

Authors:  Olav A Christophersen; Anna Haug
Journal:  Lipids Health Dis       Date:  2011-01-20       Impact factor: 3.876

4.  Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine.

Authors:  Birgit Waltenberger; Daniela Schuster; Sompol Paramapojn; Wandee Gritsanapan; Gerhard Wolber; Judith M Rollinger; Hermann Stuppner
Journal:  Phytomedicine       Date:  2010-09-20       Impact factor: 5.340

5.  Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression.

Authors:  Joseph Schwager; Ulrich Hoeller; Swen Wolfram; Nathalie Richard
Journal:  BMC Complement Altern Med       Date:  2011-11-03       Impact factor: 3.659

6.  Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Akifumi Nagatomo; Norihisa Nishida; Ikuo Fukuhara; Akira Noro; Yoshimichi Kozai; Hisao Sato; Yoichi Matsuura
Journal:  Diabetes Metab Syndr Obes       Date:  2015-03-06       Impact factor: 3.168

7.  A novel rose hip preparation with enhanced anti-inflammatory and chondroprotective effects.

Authors:  Joseph Schwager; Nathalie Richard; Rotraut Schoop; Swen Wolfram
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

Review 8.  Current status of top 10 nutraceuticals used for Knee Osteoarthritis in India.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Amish Shah; Vipul Vijay; Abhishek Vaish
Journal:  J Clin Orthop Trauma       Date:  2018-07-20

9.  Clinical evaluation of an antiinflammatory and antioxidant diet effect in 30 dogs affected by chronic otitis externa: preliminary results.

Authors:  Alessandro Di Cerbo; Sara Centenaro; Francesca Beribè; Fulvio Laus; Matteo Cerquetella; Andrea Spaterna; Gianandrea Guidetti; Sergio Canello; Giuseppe Terrazzano
Journal:  Vet Res Commun       Date:  2016-01-07       Impact factor: 2.459

10.  Assessment of rosehips based on the content of their biologically active compounds.

Authors:  Apurva Bhave; Vera Schulzova; Hana Chmelarova; Libor Mrnka; Jana Hajslova
Journal:  J Food Drug Anal       Date:  2017-02-17       Impact factor: 6.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.